Press Releases and Product Information May 4, 2022
advertisement
- Abbott, Camdiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes
- New Analysis Shows that Abbott’s Freestyle Libre System Provides Similar and Sustained Reductions in Glucose Levels For People with Both Type 1 and Type 2 Diabetes
- Dexcom study shows strong accuracy for next-gen G7 CGM in pediatric T1D patients
- The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
- Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes
- Walmart launches virtual diabetes care program